Since NPM1 mutations are present in the whole leukemic population, including LSCs from NPM1-mutated AML patients, it may be hypothesized that immune responses against NPM1-mutated protein could contribute to definitive eradication of MRD [7,19,38,39]. This evidence concerns the gene NPM1 and acute myeloid leukemia.